TRCT
NUVL

Tower Research Capital (TRC)’s Nuvalent NUVL Stock Holding History

Tower Research Capital (TRC)’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
2,008
-1,968
-49% -$212K 0.01% 1531
2026
Q1 		$407K Buy
3,976
+2,837
+249% +$289K 0.01% 1065
2025
Q4 		$115K Sell
1,139
-825
-42% -$81.3K ﹤0.01% 1853
2025
Q3 		$170K Sell
1,964
-1,178
-37% -$93.1K ﹤0.01% 1597
2025
Q2 		$240K Buy
3,142
+588
+23% +$43K 0.01% 1610
2025
Q1 		$181K Sell
2,554
-1,430
-36% -$112K 0.01% 1422
2024
Q4 		$312K Buy
3,984
+3,661
+1,133% +$342K 0.01% 1379
2024
Q3 		$33K Sell
323
-10,052
-97% -$834K ﹤0.01% 2953
2024
Q2 		$787K Buy
10,375
+8,735
+533% +$621K 0.01% 950
2024
Q1 		$123K Sell
1,640
-1,479
-47% -$118K ﹤0.01% 1716
2023
Q4 		$230K Buy
3,119
+2,476
+385% +$153K ﹤0.01% 1983
2023
Q3 		$29.6K Buy
643
+187
+41% +$8.3K ﹤0.01% 3039
2023
Q2 		$19.2K Sell
456
-8,651
-95% -$327K ﹤0.01% 3420
2023
Q1 		$238K Buy
9,107
+8,265
+982% +$244K 0.01% 1267
2022
Q4 		$25K Sell
842
-6,329
-88% -$177K ﹤0.01% 2921
2022
Q3 		$140K Sell
7,171
-6,597
-48% -$110K ﹤0.01% 2250
2022
Q2 		$187K Buy
13,768
+13,032
+1,771% +$138K ﹤0.01% 1811
2022
Q1 		$10K Sell
736
-1,192
-62% -$17.3K ﹤0.01% 4326
2021
Q4 		$37K Buy
1,928
+1,199
+164% +$26.7K ﹤0.01% 3030
2021
Q3 		$16K Buy
+729
New +$21.1K ﹤0.01% 3933

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Tower Research Capital (TRC)'s NUVL Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Nuvalent (NUVL) stake by 49% in Q2 2026, selling an estimated $212K and leaving 2,008 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #1531.

Tower Research Capital (TRC) first reported a position in NUVL in Q3 2021 and has held it in 20 quarters since. The position peaked at $787K in Q2 2024. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Tower Research Capital (TRC) held 2,008 shares of Nuvalent worth $248K as of Q2 2026.
  • Tower Research Capital (TRC) sold 1,968 Nuvalent shares in Q2 2026, an estimated $212K.
  • Nuvalent made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1531 holding.
  • Tower Research Capital (TRC) first reported a position in Nuvalent in Q3 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Nuvalent position peaked at $787K in Q2 2024.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.